Over 8 different variants of KRAS mutation have been identified at codons 12, 13 and 61 in NSCLC [37]. Several studies explored the therapeutic vulnerability and prognostic differences between the KRAS mutation subtypes [38–40]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.